Severe acute pancreatitis is a fatal systemic disease featuring acute onset, serious conditions, high incidence of complications and 20 percent-30 percent of mortality mainly due to multiple organ failure at its early stage. A research group in Hangzhou, china found that the Baicalin, main effective ingredient of Baical skullcap root, has played a protective role on renal injury of rats with SAP.
It has been confirmed that Baicalin has anti-bacterial, antiviral and anti-inflammatory activities in vitro. It also can inhibit platelet aggregation and eliminate oxygen-free radicals. Animal experiments show that Baicalin could reduce the generation of endotoxin. In addition, Baicalin has potent effect in inhibiting pancreatin which is the initial metabolite of Baicalin. All these pharmacologic actions can inhibit SAP during its multiple stages.
The research team led by Dr. Zhang Xiping from the first people's hospital of Hangzhou and second affiliated hospital of Zhejiang university spent more than five years working with experimental SAP of rats by the intravenous injection of Baicalin treatment. With the large dosage of baicalin treatment, the rats' survival rate, renal function indexes, renal gross changes and lightmicroscopic changes and its severity scores was greatly improved in end. The article clarified that the therapeutic mechanisms might be related to the inhibition of inflammatory mediators and induction of renal cells apoptosis by the application of tissue microarray technique.
So the Baicalin might be a promising therapeutic medicines in the treatment of SAP despite there are still many works to be done future.